Bid to sell reactor to Turkey raises fears

Article Abstract:

A consortium headed by Canada's AECL Ltd. is bidding on a contract to build a $4 billion nuclear power plant in Turkey. The project has sparked international controversy after a Turkish government official hinted that the plant may be used to build nuclear weapons.

New orders received, International economic relations, Nuclear Electric Power, Nuclear Electric Power Generation, Strategic alliances, Electric services, Electric utilities, Energy use, Nuclear energy, AECL Ltd.

---

Top CEOs predict grim future

Article Abstract:

A group of 150 Canadian chief executive officers has urged the world's governments to address the growing gap between rich and poor nations. The Business Council on National Issues, which is led by chairman David O'Brien, held a conference in Toronto, Ontario.

Government domestic functions, Forecasts, trends, outlooks, Administration of General Economic Programs, Intnl Economic Policy, Conferences, meetings and seminars, International economic relations, Poverty, Chief executive officers, Toronto, Ontario, Business Council on National Issues

---

AECL seeks funding to extend bid for reactors in Turkey

Article Abstract:

In order to complete its bid to sell nuclear reactors to Turkey, AECL Inc. seeks funding that will extend the proposal until Turkey is able to guarantee payment for the project.

Receipt of funds, Motor and Generator Manufacturing, Motors and generators, Nuclear Electric Generators, Finance, Nuclear power plants, AECL Inc.

Similar abstracts:

• Abstracts: Merrill set to sell off Canadian brokerage. Chapters CEO predicts more bids. Chapters hastens plan to stem on-line losses
• Abstracts: Vivendi finalizes deal for USA Networks assets. Bronfmans win in Seagram deal
• Abstracts: Blame Canada? Hollywood does. PMC slashes profit forecast. The year in mining: only a taste of what's to come
• Abstracts: Corel unloads hardware units. Entrust makes e-business investment
• Abstracts: TLC threatens legal action over Web addresses. Apotex wins legal fight over drug

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.